Plain English information about the research being conducted on Parkinson's
The clustering (or aggregation) of the protein, alpha synuclein, is a cardinal feature of the Parkinsonian brain, and it is believed to be associated with the neurodegeneration that characterises the condition. As a result, many pharmaceutical and biotech companies are focused a great deal of attention on identifying novel compounds that can enter the … Continue reading EGCG: Anyone fancy a cuppa?
We have previously written about the benefits of drinking coffee in reducing one’s chances of developing Parkinson’s disease (Click here for that post). Today, however, we shift our attention to another popular beverage: Tea. Green tea in particular. Why? Because of a secret ingredient called Epigallocatechin Gallate (or EGCG). Today’s post will discuss why EGCG may be of … Continue reading Get more EGCG. Drink green tea.
# # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2022. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles … Continue reading Monthly Research Review – October 2022
# # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during July 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles … Continue reading Monthly Research Review – July 2021
# # # # It has been reported by multiple independent research groups that tetracycline-based antibiotic drugs (such as doxycycline) have exhibited neuroprotective properties in models of Parkinson’s. Translation of these preclinical findings into the clinic has, however, been difficult. In addition, concerns have been expressed that long-term use of such agents could bring forward … Continue reading CMT-3: A better option than doxy?
# # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during July 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New … Continue reading Monthy research review – July 2020
# # # # For a some time, issues with the gastrointestinal system has been associated with Parkinson’s. For example, gut-related complaints – such as constipation and irritable bowel syndrome – are believed to be risk factors for developing the condition. Researchers have recently been exploring the bacteria that inhabit the gastrointestinal system in the … Continue reading Does Parkinson’s have us by the short and curli?
At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during March 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials (Oooh, … Continue reading Monthly Research Review: March 2020
At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical … Continue reading Monthy research review – December 2019
EDITIORIAL NOTE: Apologies to readers for the lack of content on the SoPD website this month. At the Cure Parkinson’s Trust, we have been preparing dossiers for the Linked Clinical Trials meeting in August. I will explain this process and the initiative in a future post, but for now just understand that the preparation is … Continue reading Monthly Research Review – July 2019
The Science of Parkinson's 